American Century Companies’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $200K | Buy |
+2,305
| New | +$139K | ﹤0.01% | 2778 |
|
|
2026
Q1 | – | Sell |
-34,628
| Closed | -$1.21M | – | 2853 |
|
|
2025
Q4 | $1.21M | Sell |
34,628
-851
| -2% | -$66.8K | ﹤0.01% | 2258 |
|
|
2025
Q3 | $2.95M | Sell |
35,479
-58,826
| -62% | -$4.26M | ﹤0.01% | 1927 |
|
|
2025
Q2 | $6.92M | Sell |
94,305
-20,057
| -18% | -$1.45M | ﹤0.01% | 1522 |
|
|
2025
Q1 | $13.1M | Buy |
114,362
+15,494
| +16% | +$943K | 0.01% | 1223 |
|
|
2024
Q4 | $4.98M | Buy |
98,868
+1,622
| +2% | +$85K | ﹤0.01% | 1604 |
|
|
2024
Q3 | $4.5M | Buy |
97,246
+511
| +0.5% | +$18.2K | ﹤0.01% | 1636 |
|
|
2024
Q2 | $3.14M | Sell |
96,735
-47,088
| -33% | -$1.29M | ﹤0.01% | 1706 |
|
|
2024
Q1 | $3.62M | Buy |
143,823
+104,114
| +262% | +$2.46M | ﹤0.01% | 1603 |
|
|
2023
Q4 | $1.29M | Sell |
39,709
-28,539
| -42% | -$784K | ﹤0.01% | 1967 |
|
|
2023
Q3 | $1.86M | Sell |
68,248
-39,701
| -37% | -$1.15M | ﹤0.01% | 1726 |
|
|
2023
Q2 | $2.4M | Buy |
107,949
+12,759
| +13% | +$294K | ﹤0.01% | 1586 |
|
|
2023
Q1 | $2.06M | Sell |
95,190
-22,162
| -19% | -$486K | ﹤0.01% | 1598 |
|
|
2022
Q4 | $2.38M | Buy |
117,352
+15,532
| +15% | +$389K | ﹤0.01% | 1500 |
|
|
2022
Q3 | $2.61M | Buy |
101,820
+31,174
| +44% | +$834K | ﹤0.01% | 1343 |
|
|
2022
Q2 | $1.68M | Sell |
70,646
-17,907
| -20% | -$390K | ﹤0.01% | 1494 |
|
|
2022
Q1 | $1.99M | Buy |
88,553
+6,684
| +8% | +$142K | ﹤0.01% | 1415 |
|
|
2021
Q4 | $1.62M | Buy |
81,869
+14,902
| +22% | +$302K | ﹤0.01% | 1441 |
|
|
2021
Q3 | $1.32M | Sell |
66,967
-81,164
| -55% | -$1.7M | ﹤0.01% | 1480 |
|
|
2021
Q2 | $3.26M | Sell |
148,131
-9,183
| -6% | -$204K | ﹤0.01% | 1089 |
|
|
2021
Q1 | $3.74M | Buy |
157,314
+28,385
| +22% | +$758K | ﹤0.01% | 1010 |
|
|
2020
Q4 | $3.37M | Sell |
128,929
-27,600
| -18% | -$581K | ﹤0.01% | 968 |
|
|
2020
Q3 | $2.72M | Buy |
156,529
+13,575
| +9% | +$216K | ﹤0.01% | 893 |
|
|
2020
Q2 | $2.4M | Buy |
142,954
+3,021
| +2% | +$42.4K | ﹤0.01% | 864 |
|
|
2020
Q1 | $1.66M | Buy |
139,933
+71,776
| +105% | +$888K | ﹤0.01% | 879 |
|
|
2019
Q4 | $825K | Sell |
68,157
-59,581
| -47% | -$829K | ﹤0.01% | 1113 |
|
|
2019
Q3 | $1.81M | Buy |
127,738
+14,516
| +13% | +$178K | ﹤0.01% | 984 |
|
|
2019
Q2 | $1.26M | Hold |
113,222
| – | – | ﹤0.01% | 1067 |
|
|
2019
Q1 | $1.33M | Buy |
113,222
+2,831
| +3% | +$35.2K | ﹤0.01% | 1036 |
|
|
2018
Q4 | $1.48M | Sell |
110,391
-140,159
| -56% | -$1.85M | ﹤0.01% | 1016 |
|
|
2018
Q3 | $3.51M | Buy |
250,550
+2,154
| +0.9% | +$30.1K | ﹤0.01% | 928 |
|
|
2018
Q2 | $3.9M | Sell |
248,396
-177,686
| -42% | -$3.09M | ﹤0.01% | 895 |
|
|
2018
Q1 | $7.01M | Buy |
426,082
+528
| +0.1% | +$9.78K | 0.01% | 735 |
|
|
2017
Q4 | $7.69M | Buy |
425,554
+286,194
| +205% | +$5.18M | 0.01% | 736 |
|
|
2017
Q3 | $2.69M | Buy |
+139,360
| New | +$2.08M | ﹤0.01% | 986 |
|
Other funds holding CORT
ISL
PA
American Century Companies's CORT Position: Q2 2026 in Review
American Century Companies opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 2,305 shares worth $200K. The stake represents ﹤0.01% of the portfolio and ranks #2778 among its holdings. This is a return to the name: American Century Companies previously reported a position in CORT as recently as Q4 2025.
American Century Companies first reported a position in CORT in Q3 2017 and has held it in 35 quarters since. The position peaked at $13.1M in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.
- American Century Companies held 2,305 shares of Corcept Therapeutics worth $200K as of Q2 2026.
- Corcept Therapeutics was a new American Century Companies position in Q2 2026.
- Corcept Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2778 holding.
- American Century Companies first reported a position in Corcept Therapeutics in Q3 2017 and has held it in 35 quarters since.
- American Century Companies's Corcept Therapeutics position peaked at $13.1M in Q1 2025.
- 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.